News

According to the FDA, woman using the patch would be exposed to 60% more estrogen than those taking an oral contraceptive pill, and this increase in exposure to

Eyetech’s lead product is Macugen, a treatment for age related macular degeneration (AMD), a leading cause of adult blindness. However, Genentech has recently announced positive preliminary data from

Prostate cancer is the second most common cancer in men after skin cancer and the second leading cause of cancer death in American men, exceeded only by lung

According to the study, Ink4c and Ptch1 genes collaborate to suppress the development of medulloblastoma, the most common pediatric brain tumor. This collaboration between Ink4c and Ptch1 occurs

Interim results from a pivotal phase III study of the drug were recently described in the New England Journal of Medicine as “simply stunning” and “maybe even a

The designation means that the FDA will provide input into product development plans and may accept portions of the marketing application prior to the completion of the final

A number of additional patients are in screening and the company will allow those patients to complete the process and be either randomized into the trial or disqualified,

While statins are used primarily to lower cholesterol levels, there is evidence that these drugs may also have beneficial effects on blood vessel function independent of cholesterol levels.

The company has been studying the peptides, in combination with the company’s patented Oxiplex gel as a delivery vehicle, for use in bone growth applications. The promising results